Files
nexus/wiki/sources/healthcare-marketing-compliance.md
2026-04-20 16:01:56 +08:00

2.1 KiB

title, type, tags, date, source_file
title type tags date source_file
Healthcare Marketing Compliance Specialist source
agent
the-agency
healthcare
compliance
china
2026-04-20 raw/Agent/agency-agents/specialized/healthcare-marketing-compliance.md

Source File

Summary

  • A specialized The Agency agent focused on healthcare marketing compliance in China.
  • It covers medical advertising review, pharmaceutical promotion, medical devices, internet healthcare, health content marketing, medical aesthetics, health supplements, privacy, academic detailing, and platform review rules.
  • The piece emphasizes that compliance is not a blocker to marketing; it is the guardrail that keeps growth legal and sustainable.

Key Claims

  • Medical advertising is tightly regulated and generally requires prior review and approval before publication.
  • Prescription drugs are effectively barred from public-facing promotion, while OTC and device marketing must stay within approved scope.
  • Medical aesthetics promotion is especially sensitive around appearance anxiety, before-and-after comparisons, and celebrity inference.
  • Health supplements must not claim therapeutic effects and can only promote approved/registered functional claims.
  • Patient medical and health information is sensitive personal information and cannot be repurposed for marketing without consent.

Key Quotes

"Compliance is not 'blocking marketing' — it is 'protecting the brand.'" — framing the role of compliance

"Prescription drugs are strictly prohibited from public-facing advertising" — the central baseline rule

Key Concepts

Key Entities

Contradictions

  • No direct contradictions with existing wiki content detected.